Login      Sign-Up  
Skip Navigation Links
Home
Laws
Bills
Sessions
House
Senate
Committees
Legislators
My Legis
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
House Committees
Senate Committees
Miscellaneous Committees
Scheduled Meetings
Scroll up
Scroll down
Representatives
Senators
Caucuses and Delegations
Scroll up
Scroll down

2023 Regular Session
HB548   by Representative Christopher Turner      

DRUGS/PRESCRIPTION:  Provides relative to the 340B drug pricing program (EN NO IMPACT See Note)

Current Status:  Signed by the Governor - Act 358


Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors
HB548 Act
HB548 Enrolled
HB548 Engrossed
HB548 Original
Scroll up
Scroll down
Senate Committee Amendment #1217 H&W Draft
House Committee Amendment #1541 H&W Adopted
House Committee Amendment #1432 H&W Draft
House Committee Amendment #1245 H&W Draft
Scroll up
Scroll down
Resume Digest for HB548
Digest of HB548 Engrossed
Digest of HB548 Original
Scroll up
Scroll down
Fiscal Note - HB548 Enrolled
Fiscal Note - HB548 Engrossed
Fiscal Note - HB548 Original
Scroll up
Scroll down
Senate Vote on HB 548 FINAL PASSAGE (#722)
House Vote on HB 548 FINAL PASSAGE (#135)
Scroll up
Scroll down
Christopher Turner (primary)
Alonzo Knox
Scroll up
Scroll down

 Date   ChamberJournal
Page
Action sort history by ascending dates
06/12H  Effective date: 08/01/2023.
06/12H  Signed by the Governor. Becomes Act No. 358.
06/07H  Sent to the Governor for executive approval.
06/06S86  Signed by the President of the Senate.
06/05H70  Enrolled and signed by the Speaker of the House.
06/04H4  Received from the Senate without amendments.
06/04S72  Rules suspended. Read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
05/15S3  Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
05/11S11  Read by title and referred to the Legislative Bureau.
05/10S10  Reported favorably.
04/27S3  Read second time by title and referred to the Committee on Health and Welfare.
04/26S26  Received in the Senate. Rules suspended. Read first time by title and placed on the Calendar for a second reading.
04/26H23  Read third time by title, roll called on final passage, yeas 97, nays 2. Finally passed, title adopted, ordered to the Senate.
04/24H  Scheduled for floor debate on 04/26/2023.
04/24H16  Read by title, amended, ordered engrossed, passed to 3rd reading.
04/20H19  Reported with amendments (14-0).
04/10H66  Read by title, under the rules, referred to the Committee on Health and Welfare.
04/03H  First appeared in the Interim Calendar on 4/3/2023.
03/31H  Under the rules, provisionally referred to the Committee on Health and Welfare.
03/31H  Prefiled.




If you experience any technical difficulties navigating this website, contact the webmaster.
P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062